Literature DB >> 1427073

The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

L S Tiley1, S J Madore, M H Malim, B R Cullen.   

Abstract

Among eukaryotic transcription trans-activators, the human immunodeficiency virus type 1 (HIV-1) Tat protein is exceptional in that its target site TAR is an RNA rather than a DNA sequence. Here, we confirm that fusion of Tat to the RNA-binding domain of the HIV-1 Rev protein permits the efficient activation of an HIV-1 long terminal repeat (LTR) promoter in which critical TAR sequences have been replaced by RNA sequences derived from the HIV-1 Rev response element (RRE). An RRE target sequence as small as 13 nucleotides is shown to form an effective in vivo target for Rev binding. More important, a fusion protein consisting of Rev attached to the VP16 transcription activation domain was also observed to efficiently activate the HIV-1 LTR from this nascent RNA target. These data demonstrate that trans-activation of transcription by acidic activation domains does not require a stable interaction with the promoter DNA and suggest that VP16, like Tat, can act on steps subsequent to the formation of the HIV-1 LTR preinitiation complex. The finding that the activation domains of VP16 and Tat are functionally interchangeable raises the possibility that these apparently disparate viral trans-activators may nevertheless act via similar mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1427073     DOI: 10.1101/gad.6.11.2077

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

1.  The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.

Authors:  S B Buonomo; A Michienzi; F G De Angelis; I Bozzoni
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

2.  Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element.

Authors:  Y Kang; H P Bogerd; B R Cullen
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes.

Authors:  Heather L Wiegand; Glen A Coburn; Yan Zeng; Yibin Kang; Hal P Bogerd; Bryan R Cullen
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor.

Authors:  Dona N Ho; Glen A Coburn; Yibin Kang; Bryan R Cullen; Millie M Georgiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

5.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

6.  Using viral species specificity to define a critical protein/RNA interaction surface.

Authors:  G A Coburn; H L Wiegand; Y Kang; D N Ho; M M Georgiadis; B R Cullen
Journal:  Genes Dev       Date:  2001-05-15       Impact factor: 11.361

7.  The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences.

Authors:  Y Kang; B R Cullen
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

8.  The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression.

Authors:  R A Russell; Y Zeng; O Erlwein; B R Cullen; M O McClure
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Authors:  Koh Fujinaga; Dan Irwin; Yehong Huang; Ran Taube; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

10.  Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors.

Authors:  C Suñé; M A García-Blanco
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.